Average Target Price – R$ 4,65
Consensus |
2025E |
2026E |
Net sales (R$ million) |
R$ 28,887 |
R$ 27,585 |
Gross margin (%) |
31.1% |
71.7% |
Adjusted EBITDA (R$ million) |
R$ 2,326 |
R$2,569 |
Financial result (R$ million) |
-R$ 1,299 |
-R$ 1,299 |
Net income (R$ million) |
-R$ 980 |
-R$ 578 |
TARGET PRICE (Sell) – R$ 6,70
Banco do Brasil projections |
2025E |
2026E |
Net sales (R$ million) |
R$ 28,617 |
R$ 30,336 |
Gross margin (%) |
29.3% |
30.9% |
Adjusted EBITDA (R$ million) |
R$ 2,075 |
R$ 2,230 |
Financial result (R$ million) |
R$ (2,540) |
R$ (2,509) |
Net income (R$ million) |
R$ (1,095) |
R$ (1,008) |
TARGET PRICE (Sell) – R$ 3,25
BofA Merrill Lynch projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 28,133 |
R$ 28,995 |
Gross margin (%) |
– |
– |
Adjusted EBITDA (R$ million) |
– |
– |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
-R$ 1,266 |
-R$ 914 |
TARGET PRICE (Neutral) – R$ 9,00
Bradesco projections |
2024E |
2025E |
Net sales (R$ million) |
R$ 30,512 |
R$ 32,209 |
Gross margin (%) |
– |
– |
Adjusted EBITDA (R$ million) |
R$ 3,008 |
R$ 3,207 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
– |
R$ 44 |
TARGET PRICE (Neutral) – R$ 9,00
BTG Pactual projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 28,637 |
R$ 30,108 |
Gross margin (%) |
31.6% |
32.1% |
Adjusted EBITDA (R$ million) |
R$ 2,561 |
R$ 2,859 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
-R$ 754 |
-R$ 154 |
TARGET PRICE (Neutral) – R$ 5,10
Citi projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 28,129 |
R$ 29,619 |
Gross margin (%) |
31.5% |
31.6% |
Adjusted EBITDA (R$ million) |
R$ 2,533 |
R$ 3,035 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
-R$ 489 |
-R$ 28 |
TARGET PRICE (Sell) – R$ 4,00
Genial projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 29,715 |
R$ 30,509 |
Gross margin (%) |
31.1% |
31.6% |
Adjusted EBITDA (R$ million) |
R$ 2,692 |
R$ 2,933 |
Financial result (R$ million) |
-R$ 2,326 |
-R$ 2,141 |
Net income (R$ million) |
-R$ 602 |
-R$ 327 |
TARGET PRICE (Sell) – R$ 3,20
Goldman Sachs projections |
2025E |
2026E |
Net sales (R$ million) |
R$ 28,783 |
R$ 30,366 |
Gross margin (%) |
– |
– |
Adjusted EBITDA (R$ million) |
R$ 2,447 |
R$ 2,667 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
-R$ 1,526 |
-R$ 1,526 |
TARGET PRICE (Sell) - -
Morgan Stanley projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 28,788 |
R$ 30,547 |
Gross margin (%) |
31.4% |
31.5% |
Adjusted EBITDA (R$ million) |
R$ 2,418 |
R$ 2,651 |
Financial result (R$ million) |
-R$ 2,928 |
-R$ 2,902 |
Net income (R$ million) |
-R$ 1,164 |
-R$ 1,015 |
TARGET PRICE (Sell) – R$ 3,20
Safra projections |
2025E |
2026E |
Net sales (R$ million) |
R$ 28,886 |
R$ 3,038 |
Gross margin (%) |
31.5% |
312.7% |
Adjusted EBITDA (R$ million) |
R$ 2,970 |
R$ 3,132 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
-R$ 905 |
-R$ 609 |
TARGET PRICE (Neutral) – R$ 3,90
Santander projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 28,674 |
R$ 30,126 |
Gross margin (%) |
31.5% |
31.5% |
Adjusted EBITDA (R$ million) |
R$ 2,552 |
R$ 2,976 |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
– R$ 1,020 |
– R$ 527 |
TARGET PRICE (Neutral)) – R$ 8.00
XP projections |
2025E |
2026E |
Net sales(R$ million) |
R$ 8.00 |
– |
Gross margin (%) |
– |
– |
Adjusted EBITDA (R$ million) |
– |
– |
Financial result (R$ million) |
– |
– |
Net income (R$ million) |
– |
– |